Axxess Pharma, Inc. (AXXE: OTC Pink Current) | Axxess

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Axxess Pharma, Inc. (AXXE: OTC Pink Current) | Axxess Pharma Receives 2013 Canadian Excellence Award From the United States Trade and Commerce Institute (USTCI) Axxess Pharma Receives 2013 Canadian Excellence Award From the United States Trade and Commerce Institute (USTCI)

Axxess Pharma Receives 2013 Canadian Excellence Award From the United States Trade and Commerce Institute (USTCI)

Award Confirms Continued Sales and Marketing Achievements Throughout North America

TORONTO, ON--(Marketwired - May 22, 2014) - Axxess Pharma Inc. ( PINKSHEETS : AXXE ), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce they have received a 2013 Canadian Excellence Award from the United States Trade and Commerce Institute (USTCI). This award provides further indication of Axxess Pharmas continued growth throughout North America.

The USTCI is a leading authority on researching, evaluating and recognizing companies across a wide spectrum of industries that meet its stringent standards of excellence. It has spearheaded the idea of independent enterprise and entrepreneurial growth allowing businesses of all sizes to be recognized locally and encouraged globally.

Particular emphasis is given to meeting and exceeding industry benchmarks for customer service, product quality and ethical practices. Industry leading standards and practices have been developed and implementation of the same has been pioneered by the dedicated efforts of the business community and commerce leadership.

The award from USTCI is one of many accomplishments by Axxess Pharma. Below are the latest achievements during the last 45 days.

  • Omega-3 Fish Oil: Axxess Pharma to Launch Omega-3 Fish Oil Supplement to US retail and online market by July 1st.
  • Rev-Nutrition.com: Axxess Pharma Inc. reports Tapout Muscle Explosion supplement has quickly become one of Rev-Nutrition's top selling products. 
  • MMA Light Heavyweight Spokesperson: Axxess Pharma Inc. Signs Mixed Martial Arts Light Heavyweight Fighter Ryan 'Big Deal' Jimmo as Spokesperson.
  • Research Report (Update): Murphy Analytics Announces Update of Coverage on Axxess Pharma Inc. To view updated research report, click on link: http://www.murphyanalytics.com/uploads/AXXE_Update.pdf . 
  • Vitamin World Stores: TapouT's best selling Muscle Explosion product now available in select Vitamin World Stores.
  • US Military: TapouT line of Pain Relief and Muscle Growth products have been approved for sale in exchanges world-wide by a branch of the US military serving active service memebrs and their families as well as retirees.
  • Amazon.com: The largest world-wide on-line retailer Amazon.com sells out initial order of TapouT pain relief products and places second order.
  • Go4ITNutrition: AllStar Health Brands receives Additional purchase order for TapouT Muscle Recovery products from Go4ITNutrition.com, a massive online marketplace that deals specifically in sports supplements and sports nutrition products. The website features hundreds of the top brands in the industry.
  • BIOVEA: High-profile international online sales company and leading manufacturer/distributor, BIOVEA placed an initial order for the TapouT-branded Pain Relief product line.
  • Victory Brands, Inc.: Leading Canadian distributor places additional purchase order for AllStar Health Brands TapouT branded product line. Continued re-orders from Victory Brands steadily increasing momentum of Canadian sales.
  • Meeting with Large Size Retailers: Axxess Pharma Inc. & All Star Health Brands to Meet With Some of the Largest Retailers in the United States at ECRM EPPS Event.

Dr. Daniel Bagi, President of Axxess Pharma, stated, "We are honored to receive the 2013 Canadian Excellence Award from the USTCI. This provides further confirmation, that our company is gaining attention for quality products and service. We anticipate record revenue growth in 2014."

About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements. To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, please visit: http://buytapoutme.com and http://www.tapoutmusclerecovery.com .

About TapouT: TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com.

https://www.facebook.com/TapouT
https://twitter.com/TapouT
http://www.youtube.com/tapout

Safe Harbor Statement

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

Contact:
Investor Relations
Taylor Capitol, Inc.
Stephen Taylor
(973) 351-3868
staylor@TheStockAlerts.com
www.TheStockAlerts.com

Media Relations:
Jamie Schnee- PR
Nutritional Products International
(561) 544-0719

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 73

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
Banco Macro S.A. Plans $160B Share Buyback Initiative

Updated Category News Views 24

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Continue Reading
Enertech's New Moves Aim to Make Geothermal Mainstream

Updated Category News Views 74

Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...

Continue Reading
Agrochemicals: Combining Tradition and Innovation

Updated Category News Views 69

The Evolving World of Agrochemicals You know, the agrochemical market isn't just about fertilizers and pesticides anymore. It's evolving into a high-stakes game of innovation, resistance management, and cutting-edge tech. This whole sector's forecast to explode to a whopping US$ 387.7 billion by 2031. That's no small potatoes. Driving Forces: Pests, Drones, and Regulatory...

Continue Reading
Insurify's AI Gateway: A New Era in Insurance Shopping

Updated Category News Views 66

Insurify's Game-Changing AI Agent Gateway In the insurance world, Insurify's latest move feels like a bull charging through a ticker tape parade. This Cambridge-based pioneer unveiled its AI Agent Gateway, aiming to put consumers back in the driver's seat. By connecting digital assistant agents to its platform, Insurify's making insurance shopping a bit less like pulling...

Continue Reading
Royce Micro-Cap Trust: Navigating Small-Cap Waves

Updated Category News Views 42

Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 99

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 68

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 111

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading
Royce Small-Cap Trust Shows Resilience Amid Volatility

Updated Category News Views 95

A Closer Look at Royce's Latest Moves Royce Small-Cap Trust (NYSE: RVT), the venerable old timer in the small-cap fund world, has been trucking along the market's bumpy byways since forever ago. With over 50 years of small- and micro-cap investment experience under its belt, you'd think it might have seen everything by now. But in the volatile world of small caps,...

Continue Reading

Top 5 Most Recently Viewed Articles

Gen Z Hacks Loyalty Programs with AI Power Play

Updated Category News Views 15

Gen Z Leads the Charge in AI-Driven Loyalty The times, they are a-changin', and loyalty programs aren't immune. Hopping on the AI bandwagon, 64% of Gen Z in the UK and 55% in the US are getting more bang for their buck, utilizing AI to optimize their participation and rake in rewards. According to Comarch's latest findings, these young savants aren't just after luxury...

Continue Reading
SendCutSend Triumphs in American Business Awards with Gold

Updated Category News Views 302

SendCutSend Wins Gold Stevie Award at American Business Awards SendCutSend has received a significant honor by winning a coveted Gold Stevie Award in the Manufacturing category during the American Business Awards. This prestigious award program recognizes excellence in various sectors across the country. The awards attracted over 3,600 submissions from multiple...

Continue Reading
Explore the Glow Up Golden Calendar for 2026 Launch

Updated Category News Views 393

Glow Up Golden 2026 Calendar Unveiled at Pearl River Mart -Inspired by ancient Chinese timing to support modern decision-making- In a vibrant new partnership, Julie Huang, renowned writer and Chinese metaphysics practitioner, is set to launch the Glow Up Golden 2026 Calendar at Pearl River Mart. This culturally enriching calendar draws on classical Chinese wisdom, making...

Continue Reading
Luminar Technologies Faces Lawsuit: Investors Take Action

Updated Category News Views 278

Investors Encouraged to Act on Luminar Technologies Lawsuit The focus is now on Luminar Technologies, Inc. (NASDAQ: LAZR) as the opportunity arises for investors to join a significant class action lawsuit. This comes in light of recent allegations of securities fraud within the company. Investors who purchased Luminar securities within the specified time frame are urged...

Continue Reading
Understanding Recent Trends in Catalyst Pharmaceuticals' Short Interest

Updated Category News Views 176

Recent Trends in Catalyst Pharmaceuticals' Short Interest Catalyst Pharmaceuticals (CPRX) has seen a notable increase in its short percent of float, jumping by 5.8% since the last report. The latest figures indicate that about 8.17 million shares are currently sold short, representing 8.57% of all shares available for trading. Based on trading volume, it would take...

Continue Reading